Skip to main content

LCD L34577: Retroperitoneal Ultrasound

LCD L34577, Retroperitoneal Ultrasound, is the Local Coverage Determination that Palmetto GBA applies to claims from 7 states (AL, GA, NC, SC, TN, VA, WV), effective 2019-11-07 and first in force 2015-10-01. The policy text runs 432 words, and its billing and coding article A55336 lists 797 ICD-10-CM codes that support medical necessity for 3 procedure codes. No other contractor publishes a policy with this title.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database LCD export release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (Thursdays) for the MCD.
Contractor
Palmetto GBA
States and territories
7
AL GA NC SC TN VA WV
Revision effective
2019-11-07
Original effective
2015-10-01
Policy text
432 words
Covered ICD-10 codes (articles)
797

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34577
ContractContractorTypeStates
11201Palmetto GBAA and B and HHH MACSC
11301Palmetto GBAA and B and HHH MACVA
11401Palmetto GBAA and B and HHH MACWV
11501Palmetto GBAA and B and HHH MACNC
11202Palmetto GBAA and B and HHH MACSC
11302Palmetto GBAA and B and HHH MACVA
11402Palmetto GBAA and B and HHH MACWV
11502Palmetto GBAA and B and HHH MACNC
10111Palmetto GBAA and B MACAL
10211Palmetto GBAA and B MACGA
10311Palmetto GBAA and B MACTN
10112Palmetto GBAA and B MACAL
10212Palmetto GBAA and B MACGA
10312Palmetto GBAA and B MACTN

Billing and coding: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A55336 (Billing and Coding: Retroperitoneal Ultrasound) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown.

A55336: Billing and Coding: Retroperitoneal Ultrasound (Billing and Coding, effective 2025-10-01)

Covered ICD-10-CM codes
797
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
3
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A55336
ICD-10-CMDescription (FY2027)
B25.2—
B52.0—
C25.0—
C25.1—
C25.2—
C25.3—
C25.4—
C25.7—
C25.8—
C25.9—
C48.0—
C48.8—
C61Malignant neoplasm of prostate
C64.1—
C64.2—
C65.1—
C65.2—
C66.1—
C66.2—
C67.9—
C68.0—
C68.1—
C68.8—
C78.6—

Procedure codes: 76770, 76775, 76776.

Coverage indications, limitations and medical necessity

Retroperitoneal ultrasound (US) studies represent the ultrasonic imaging of retroperitoneal organs for the diagnosis and management of abnormalities that occur within the retroperitoneum. A complete retroperitoneal US study visualizes all the structures or organs within the anatomic description of that study. A limited study involves an imaging of only a single quadrant, a single diagnostic problem, or an evaluation of a specific organ of interest. Retroperitoneal ultrasonography may be considered reasonable and necessary for the diagnosis and treatment of the following organs and retroperitoneal structures:

1. Pancreas

2. Abdominal aorta- US is accurate for aortic measurement and may be used to follow patients with aortic aneurysms.

3. Inferior vena cava - US is useful in the detection of invasion by adjacent tumors and identification of obstruction levels.

4. Kidneys, ureter, and bladder:

a) Kidneys-

i) May confirm scarred or small kidneys in chronic renal cortical disease (but may be of no use in detecting early or mild cortical disorders or to categorize specific types of cortical diseases).

ii) May be useful in detecting and following renal cysts and localizing solid masses.

iii) May be useful as a primary diagnostic tool in patients with suspected renal disease.

b) Ureter- Normal ureters are usually not well visualized by US, especially in their mid-portions. Renal US is the primary mode of diagnosis of a renal obstruction which is demonstrated by dilated ureters. It may be helpful in identifying filling defects or a mass, in its most proximal or distal portions. US has no role in vesicular ureteral reflux.

c) Bladder- Tumors of the bladder are most efficiently followed by cystoscopy and urography. However, US is useful in following intraluminal bladder tumors with or without extraluminal extension, including evaluation of bladder wall thickness and irregularity and evaluating post void residual at the bedside.

5. Renal transplants- US is indicated to detect urinary obstruction, fluid collection, and complications of renal transplants and is considered a primary tool in this endeavor. The presence or absence of signs and symptoms dictate utilization frequency of this modality for renal transplants.

6. Adenopathy- Computed tomography (CT) is far more accurate than US in detecting and delineating adenopathy. US in this instance should be considered secondary and rarely utilized in the detection or follow up of nodal disease.

7. Prostate- Evaluation of the prostate is primarily done transrectally by US.

8. Adrenal Gland- US is of little value since a CT scan is considered more accurate.

9. Organs located in the retroperitoneal region- US may be helpful in the evaluation of wounds, contusions, and lacerations of organs located in the retroperitoneal region.

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2019-11-07
Last reviewed by the contractor
2019-05-29
MCD version
64
Derived from
L31601

The contractor lists one National Coverage Determination as related: NCD 220.5 Ultrasound Diagnostic Procedures. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line, and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Palmetto GBA hub lists every other active policy from the same contractor.

Frequently asked questions

What does LCD L34577 cover?

Retroperitoneal ultrasound (US) studies represent the ultrasonic imaging of retroperitoneal organs for the diagnosis and management of abnormalities that occur within the retroperitoneum. A complete retroperitoneal US study visualizes all the structures or organs within the anatomic description of that study. A limited study involves an imaging of only a single quadrant, a single diagnostic problem, or an… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database export of September 24, 2026.

Which states does LCD L34577 apply to?

Palmetto GBA applies it to Medicare claims in AL, GA, NC, SC, TN, VA, WV. A Local Coverage Determination binds only the contractor that wrote it; the same service in another jurisdiction is judged under that contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34577?

The companion billing and coding article A55336 lists 797 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page and the complete list is in the article on cms.gov.

How do I appeal a denial under LCD L34577?

The remittance carries claim adjustment reason code 50 with remark code N115, naming the LCD. Compare the documented indication with the policy's covered indications and the article's diagnosis list, then file a redetermination within 120 days with the record attached; if the service genuinely falls outside the policy, the patient can be billed only when a valid Advance Beneficiary Notice was obtained before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.